Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

Полное описание

Библиографические подробности

Главные авторы:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Open Exploration Publishing Inc. 2026-04-01
Серии:	Exploration of Targeted Anti-tumor Therapy
Предметы:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
Online-ссылка:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!